The average half-life of peptide and protein drugs is shorter than that of small molecule therapeutics due to the enzymatic action of peptidases and proteases.

Name: The average half-life of peptide and protein drugs is shorter than that of small molecule therapeutics due to the enzymatic action of peptidases and proteases.
Brand: Quizplus
Rating: 4.8 (60 reviews)

Question

Quizplus · Accepted Answer

Peptide and protein drugs are more susceptible to enzymatic degradation by peptidases and proteases, leading to a shorter half-life compared to small molecule therapeutics.

The Average Half-Life of Peptide and Protein Drugs Is Shorter